The most common condition of inherited blindness due to mitochondria! chromosomal anomaly is:
**Question:** The most common condition of inherited blindness due to mitochondria! chromosomal anomaly is:
A. Leber Hereditary Optic Neuropathy (LHON)
B. Mitochondrial Carnitine O-Acetyltransferase Deficiency (MCAD)
C. Mitochondrial OXPHOS Deficiency
D. Mitochondrial DNA Depletion Syndrome
**Correct Answer:** C. Mitochondrial OXPHOS Deficiency
**Core Concept:** Mitochondrial disorders are a group of genetic diseases caused by abnormalities in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) genes that regulate mitochondrial function. Mitochondrial dysfunction affects cellular energy production, resulting in various clinical manifestations, including inherited blindness.
**Why the Correct Answer is Right:** Mitochondrial OXPHOS (oxidative phosphorylation) deficiency is a group of genetic disorders caused by defects in the nuclear-encoded proteins involved in oxidative phosphorylation, the process that drives ATP production in mitochondria. This deficiency leads to impaired energy production in retinal ganglion cells, resulting in inherited blindness as a common symptom.
**Why Each Wrong Option is Incorrect:**
A. Leber Hereditary Optic Neuropathy (LHON) is a mitochondrial disorder caused by mtDNA mutations, affecting optic nerve function, but it is not due to a deficiency in oxidative phosphorylation.
B. Mitochondrial Carnitine O-Acetyltransferase Deficiency (MCAD) is a disorder of fatty acid oxidation, caused by nDNA mutations, not directly related to oxidative phosphorylation or inherited blindness.
D. Mitochondrial DNA Depletion Syndrome is a group of disorders caused by mtDNA mutations, resulting in global tissue hypoxemia due to reduced mtDNA content, not specifically related to oxidative phosphorylation or inherited blindness.
**Clinical Pearl:** Inherited blindness due to mitochondrial disorders is a reminder of the importance of considering mitochondrial dysfunction in patients with bilateral optic atrophy and a family history, even in the absence of other systemic manifestations. Early diagnosis and treatment can significantly improve visual outcomes.